Pacira Pharmaceuticals (82P) Ownership - Who Owns Pacira Pharmaceuticals?
Pacira Pharmaceuticals (82P) Ownership Overview
- 3.65% Insiders
- 24.11% Mutual Funds
- 2.87% Other Institutional Investors
- 33.24% ETFs
- 36.13% Public Companies and Individual Investors
The ownership structure of Pacira Pharmaceuticals (DE:82P) stock is a mix of institutional, retail, and individual investors. Approximately 60.22% of the company’s stock is owned by Institutional Investors, 3.65% is owned by Insiders, and 36.13% is owned by Public Companies and Individual Investors.
The ownership structure of Pacira Pharmaceuticals (DE:82P) stock is a mix of institutional, retail, and individual investors. Approximately 60.22% of the company’s stock is owned by Institutional Investors, 3.65% is owned by Insiders, and 36.13% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 18, 2026 | Mark Froimson | $10,905 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Entrypoint Capital, Llc | €677,590 | |
| Dec 31, 2025 | Hussman Strategic Advisors Inc | €3,260,880 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 4,529,972 | Institution | 11.36% | 163,450,450 |
| Vanguard | 3,521,055 | Institution | 8.83% | 127,046,707 |
| Vanguard Index Funds | 3,051,635 | Institution | 7.66% | 110,109,094 |
| Dfa Investment Dimensions Group Inc | 1,207,125 | Institution | 3.03% | 43,555,484 |
| Avantis | 1,174,620 | Institution | 2.95% | 42,382,639 |
| Spdr | 1,157,466 | Institution | 2.90% | 41,763,688 |
| Impax Funds Series Trust I | 750,027 | Institution | 1.88% | 27,062,474 |
| Frank D. Lee | 660,830 | Insider | 1.66% | 23,844,068 |
| Fidelity Salem Street Trust | 492,429 | Institution | 1.24% | 17,767,823 |
| Schwab | 456,878 | Institution | 1.15% | 16,485,072 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 3,051,635 | Institution | 7.66% | 110,109,094 |
| Dfa Investment Dimensions Group Inc | 1,207,125 | Institution | 3.03% | 43,555,484 |
| Impax Funds Series Trust I | 750,027 | Institution | 1.88% | 27,062,474 |
| Fidelity Salem Street Trust | 492,429 | Institution | 1.24% | 17,767,823 |
| Vanguard Scottsdale Funds | 443,508 | Institution | 1.11% | 16,002,656 |
| Fidelity Concord Street Trust | 363,846 | Institution | 0.91% | 13,128,291 |
| Deutsche Dws Investment Trust | 349,906 | Institution | 0.88% | 12,625,308 |
| T. Rowe Price Quantitative Management Funds, Inc. | 260,100 | Institution | 0.65% | 9,384,928 |
| Schwab Capital Trust | 259,763 | Institution | 0.65% | 9,372,769 |
| Vanguard Tax-managed Funds | 253,547 | Institution | 0.64% | 9,148,483 |
FAQ
Who Owns Pacira Pharmaceuticals (DE:82P)?
According to the latest TipRanks data, approximately 60.22% of the company's stock is held by institutional investors, 3.65% is held by insiders, and 36.13% is held by public companies and individual investors.
What percentage of Pacira Pharmaceuticals (DE:82P) stock is held by institutional investors?
According to the latest TipRanks data, approximately 60.22% of Pacira Pharmaceuticals (DE:82P) stock is held by institutional investors: 24.11% by mutual funds, 33.24% by ETFs and 2.87% by other institutional investors.
What percentage of Pacira Pharmaceuticals (DE:82P) stock is held by retail investors?
According to the latest TipRanks data, approximately 36.13% of Pacira Pharmaceuticals (DE:82P) stock is held by public companies and individual investors.
Who owns the most shares of Pacira Pharmaceuticals (DE:82P)?
iShares owns the most shares of Pacira Pharmaceuticals (DE:82P).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.